James Palacino

James Palacino

Company: Orum Therapeutics

Job title: Vice President & Head of Biology


Development of TPD² – Combining the Power of Protein Degradation With the Precision of Antibodies for Next-Generation ADCs 8:30 am

Examining the potency of GSPT1 degrader as a payload Discussing improved pharmacokinetic properties Outlining improved safety and tolerabilityRead more

day: Scientific Program Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.